14 October 2019
US-based clinical trials software firm Florence has raised $7.1m in a Series B funding round to create digital connectivity between trial sites and sponsors.
11 October 2019
Clinical trials technology provider VirTrial has formed an alliance to enable virtual clinical trials at Pratia clinical research centres in Europe.
10 October 2019
Biopharmaceutical services provider Parexel has entered a multi-year collaboration with healthcare data services firm Datavant to link real-world data across clinical trials.
11 September 2019
VBI Vaccines has partnered with GlaxoSmithKline (GSK) to assess the combination of its cancer vaccine immunotherapeutic VBI-1901 with GSK’s AS01B adjuvant system.
19 July 2019
Bristol-Myers Squibb (BMS), Ono Pharmaceutical, and Bayer have signed a clinical collaboration agreement to trial a combination therapy for the treatment of microsatellite stable metastatic colorectal cancer (MSS mCRC).
11 June 2019
CStone Pharmaceuticals has collaborated with Bayer HealthCare to study the combination of its investigational drug CS1001 with Bayer’s regorafenib to treat various cancers, including gastric cancer.
29 November 2018
Aileron Therapeutics has entered a clinical trial collaboration to evaluate the combination of its ALRN-6924 and Pfizer’s palbociclib in MDM2-amplified cancers.
28 November 2018
Generex Biotechnology will manage a Phase II clinical trial of pembrolizumab (keytruda) for the treatment of patients with metastatic triple negative breast cancer after signing an agreement with the NSABP...
19 October 2018
AELIX Therapeutics and Gilead Sciences have entered a joint clinical research collaboration for the analysis of proprietary investigational products.
28 September 2018
Australian biotechnology company Immutep has entered a clinical trial collaboration agreement with Merck and Pfizer to develop a new cancer immunotherapy combination therapy.